Skip to main content
HairCited

철분 관련 철분 결핍성 탈모

A

총 30,034명의 참여자를 대상으로 한 73건의 연구(메타분석 4건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Diron\u002Ddeficiency\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Iron deficiency is clearly linked to hair loss, and correcting a genuine deficiency may support hair regrowth, but iron supplementation is not universally effective for all types of hair loss.

  • 73 studies across 30,034 participants provide extensive evidence on the iron-hair loss connection
  • Low serum ferritin levels are frequently observed in patients with hair loss
  • Supplementation appears most beneficial when a true iron deficiency is documented
  • Iron supplementation without confirmed deficiency may not improve hair outcomes and can carry risks

Key Study Findings

review
[Restless leg syndrome. Diagnosis and treatment].
Dose: various vs: Placebo 효과: None None
case-control n=90
Restless Leg Syndrome and Association with Serum NT Pro-CNP.
Dose: None vs: Placebo 효과: NT pro-CNP significantly lower in RLS vs controls; sensitivity 80%, specificity 88.9%; serum iron lo None
cross-sectional n=150
Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic …
Dose: None vs: Placebo 효과: RLS prevalence 42%; serum ferritin lower in RLS (88.4 vs 126.7 ng/mL); TSAT lower (16.3% vs 22.1%); p < 0.01
review
Restless Leg Syndrome and Pregnancy.
Dose: iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) vs: Placebo 효과: None None
cross-sectional study n=100
Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
Dose: not applicable (observational; serum ferritin measured) vs: Placebo 효과: mean ferritin 24.30 vs 44.78 ng/mL < 0.001

Key Statistics

73

연구

30034

참여자

Mixed

A

등급

Referenced Papers

Revista de neurologia None 8 인용
Southern medical journal 2025
Tremor and other … 2023 32 인용
Acta dermatovenerologica Croatica … 2016 6 인용
Biometals : an … 2016
Sleep medicine clinics 2015 158 인용
Handbook of clinical … 2014 52 인용
Nephro-urology monthly 2014 43 인용
Annals of gastroenterology 2014 5 인용
Turkish journal of … 2014 5 인용
Skin pharmacology and … 2013 127 인용
Indian journal of … 2011 75 인용
The Israel Medical … 2008 61 인용
American journal of … 2007 61 인용
Seminars in cutaneous … 2006 23 인용
Sleep medicine reviews 2001 48 인용
Dermatologic clinics 1993 38 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
18 mg/day (women)
deficiency:
65-200 mg elemental iron/day

상한량: 45 mg/day

연구에서 사용된 용량

용량 기간 효과 N
various -- Positive --
None -- Positive 90
None -- Positive --
None -- Positive 150
iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) -- Positive --
not applicable (observational; serum ferritin measured) -- Negative 100
None -- Neutral 113
None -- Neutral 2851

권장 복용 시간: On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

보고된 부작용

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

알려진 상호작용

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

일일 최대 섭취 허용량: 45 mg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 철분 help with 철분 결핍성 탈모?
Based on 73 studies with 30,034 participants, there is strong evidence from multiple clinical trials that 철분 may support 철분 결핍성 탈모 management. Our evidence grade is A (Strong Evidence).
How much 철분 should I take for 철분 결핍성 탈모?
Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 철분?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 철분 and 철분 결핍성 탈모?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 73 peer-reviewed studies with 30,034 total participants. The overall direction of effect is mixed.

Related Evidence

관련 다른 성분: 철분 결핍성 탈모

철분 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.